In vitro effect of hemodilution on activated clotting time and high-dose thrombin time during cardiopulmonary bypass

Annals of Thoracic Surgery

Volumn 62, Issue 2, 1996, Pages 533-537

  Huyzen, Robert J ^a   Van Oeveren, Willem ^a   Feiyan, Wei ^a   Stellingwerf, Pieter ^a   Boonstra, Piet W ^a   Gu Y, J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN;

ADULT; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING TIME; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; HEMODILUTION; HEPARINIZATION; HUMAN; PRIORITY JOURNAL; SURGICAL PATIENT; THROMBIN TIME;

EID: 0030218907     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/0003-4975(96)00386-4     Document Type: Article

References (19)

1. 1. Bull BS, Korpman RA, Huse WM, Briggs BD. Heparin therapy during extracorporeal circulation: I. Problems inherent in existing heparin protocols. J Thorac Cardiovasc Surg 1975;69:674-84.
2. 2. Hattersley PG. Activated coagulation time of whole blood. JAMA 1966;196:436-40.
3. 3. Gravlee GP, Haddon WS, Rothberger HK, et al. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation. J Thorac Cardiovasc Surg 1990;99:518-27.
4. 4. Huyzen RJ, Harder MP, Gallandat Huet RCG, et al. Alternative anticoagulation monitoring during cardiopulmonary bypass in aprotinin treated patients. J Thorac Cardiovasc Anaesth 1994;8:153-6.
5. 5. Cohen EJ, Cameriengo LJ, Dearing JP. Activated clotting times and cardiopulmonary bypass I: the effect of hemodilution and hypothermia upon activated clotting time. J Extracorporeal Technol 1980;12:139-41.
6. 6. Culliford AT, Gitel SN, Starr N, et al. Lack of correlation between activated clotting time and plasma heparin during cardiopulmonary bypass. Ann Surg 1981;193:105-11.
7. 7. Penner JA. Experience with a thrombin clotting time assay for measuring heparin activity. Am J Clin Pathol 1973;61:645-53.
8. 8. Wang JS, Lin CY, Karp RB. Comparison of high dose thrombin time with activated clotting time for monitoring of anticoagulant effects of heparin in cardiac surgical patients. Anesth Analg 1994;79:9-13.
9. 9. Kern FH, Morana NJ, Sears JJ, Hickey PR. Coagulation defects in neonates during cardiopulmonary bypass. Ann Thorac Surg 1992;54:541-6.
10. 10. Gu YJ, Huyzen RJ, van Oeveren W. Intrinsic pathway-dependent activated clotting time is not reliable for monitoring anticoagulation during cardiopulmonary bypass in neonates. J Thorac Cardiovasc Surg 1996;111:677-8.
11. 11. Kriesmer P, Payne NR, Tessmer J, Uden DL. Activated clotting time tests with heparinase in the management of pediatric patients on cardiopulmonary bypass. ASAIO J 1993;39:942-5.
12. 12. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the full-term infant. Blood 1987;70:165-72.
13. 13. Jobes DR, Nicolson SC, Steven JM. Inhibition and restoration of hemostasis in the young cardiac surgical patient. Cardiol Young 1993;3:370-7.
14. 14. Manno CS, Hedberg KW, Kim HC, et al. Comparison of the hemostatic effect of fresh whole blood, stored whole blood, and components after open heart surgery in children. Blood 1991;77:930-6.
15. 15. Hashimoto K, Yamagishi M, Sasaki T, Nakano M, Kurosawa H. Heparin and antithrombin III levels during cardiopulmonary bypass: correlation with subclinical plasma coagulation. Ann Thorac Surg 1994;58:799-805.
16. 16. Kumar R, Béguin S, Hemker HC. The influence of fibrinogen and fibrin on thrombin generation - evidence for feedback activation of the clotting system by clot bound thrombin. Thromb Haemost 1994;72:713-21.
17. 17. Young J, Kisker C, Doty D. Adequate anticoagulation during cardiopulmonary bypass determined by activated clotting time and the appearance of fibrin monomer. Ann Thorac Surg 1978;26:231-40.
18. 18. Boisclair MD, Lane DA, Phillippou H, et al. Mechanisms of thrombin generation during surgery and cardiopulmonary bypass. Blood 1993;82:3350-7.
19. 19. Dietrich W, Spannagl M, Schramm W, Vogt W, Barankay A, Richter JA. The influence of preoperative anticoagulation on heparin response during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1991;102:505-14.